Stocktoria
Medinotec Inc. MDNC
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2023-03-21
Medinotec Inc. financials (annual, from 10-K)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $9.7M | $9.1M | $5.0M | $999,579 |
| Gross profit | $5.1M | $4.8M | $2.4M | $581,822 |
| R&D expense | $149,858 | $91,133 | -$22,351 | -$64,866 |
| Operating income | $1.1M | $3.2M | $600,578 | -$238,587 |
| Interest expense | $87,595 | $176,416 | -$277,230 | -$226,814 |
| Income tax | -$274,685 | -$864,665 | -$150,918 | $38,742 |
| Net income | $794,502 | $2.2M | -$404,688 | -$352,735 |
| Operating cash flow | $952,541 | $1.1M | $96,540 | -$490,549 |
| Free cash flow | $951,178 | $1.1M | $98,795 | -$545,826 |
| Total assets | $6.8M | $6.8M | $4.8M | $4.5M |
| Total liabilities | $1.1M | $2.5M | $2.6M | $1.9M |
| Shareholders' equity | $5.7M | $4.3M | $2.2M | $2.6M |
Growth · year-over-year · Revenue CAGR 113.5%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +6.8% | +81.5% | +402.3% | — |
| Net income growth | -63.2% | — | — | — |
| Free cash flow growth | -9.9% | +968.1% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001931055 · as of 2026-02-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.